Literature DB >> 32329568

Dealing with a critical national shortage-Approaches to triaging immune globulin supply in pediatric hematology and oncology.

Holly J Edington1,2, Kathryn S Sutton1,2, Carolyn Bennett1,2, Shanmuganathan Chandrakasan1,2, Jennifer Sterner-Allison3, Sharon M Castellino1,2.   

Abstract

Entities:  

Keywords:  IVIG; immunodeficiency; immunomodulation; pediatric use

Mesh：

Substances：

Year:  2020        PMID： 32329568      PMCID： PMC7477917          DOI： 10.1002/pbc.28260

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  18 in total

Review 1.  Update on the use of immunoglobulin in human disease: A review of evidence.

Authors:  Elena E Perez; Jordan S Orange; Francisco Bonilla; Javier Chinen; Ivan K Chinn; Morna Dorsey; Yehia El-Gamal; Terry O Harville; Elham Hossny; Bruce Mazer; Robert Nelson; Elizabeth Secord; Stanley C Jordan; E Richard Stiehm; Ashley A Vo; Mark Ballow
Journal:  J Allergy Clin Immunol       Date:  2016-12-29       Impact factor: 10.793

2.  Intravenous immune globulin shortage: experience at a large children's hospital.

Authors:  K D Gurwitch; M A Goldwire; C J Baker
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

3.  Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia.

Authors:  T E Caver; K S Slobod; P M Flynn; F G Behm; M M Hudson; E V Turner; R G Webster; J M Boyett; T L Tassie; C H Pui; J L Hurwitz
Journal:  Leukemia       Date:  1998-04       Impact factor: 11.528

Review 4.  RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).

Authors:  Jenny M Despotovic; Michele P Lambert; Jay H Herman; Terry B Gernsheimer; Keith R McCrae; Michael D Tarantino; James B Bussel
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

5.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

6.  Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases.

Authors:  Cornelis M van Tilburg; Marc B Bierings; Guy A M Berbers; Tom F W Wolfs; Rob Pieters; Andries C Bloem; Elisabeth A M Sanders
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

7.  American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Authors:  Cindy Neunert; Deirdra R Terrell; Donald M Arnold; George Buchanan; Douglas B Cines; Nichola Cooper; Adam Cuker; Jenny M Despotovic; James N George; Rachael F Grace; Thomas Kühne; David J Kuter; Wendy Lim; Keith R McCrae; Barbara Pruitt; Hayley Shimanek; Sara K Vesely
Journal:  Blood Adv       Date:  2019-12-10

Review 8.  Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.

Authors:  Pia Raanani; Anat Gafter-Gvili; Mical Paul; Isaac Ben-Bassat; Leonard Leibovici; Ofer Shpilberg
Journal:  Leuk Lymphoma       Date:  2009-05

9.  An Ethical Framework for Allocating Scarce Life-Saving Chemotherapy and Supportive Care Drugs for Childhood Cancer.

Authors:  Yoram Unguru; Conrad V Fernandez; Brooke Bernhardt; Stacey Berg; Kim Pyke-Grimm; Catherine Woodman; Steven Joffe
Journal:  J Natl Cancer Inst       Date:  2016-01-29       Impact factor: 13.506

10.  Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

Authors:  Pedro A de Alarcon; Katherine K Matthay; Wendy B London; Arlene Naranjo; Sheena C Tenney; Jessica A Panzer; Michael D Hogarty; Julie R Park; John M Maris; Susan L Cohn
Journal:  Lancet Child Adolesc Health       Date:  2017-11-03
View more
  3 in total

Review 1.  Neutropenia and Infection Prophylaxis in Childhood Cancer.

Authors:  Stephanie Villeneuve; Catherine Aftandilian
Journal:  Curr Oncol Rep       Date:  2022-03-01       Impact factor: 5.945

2.  Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies.

Authors:  Elena E Perez; Jacques Hébert; Anne K Ellis; Oral Alpan; William R Lumry; Ralph Shapiro; Daniel Suez; J Fernando Mandujano; Richard L Wasserman
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

3.  Guillain-Barré syndrome in times of pandemics.

Authors:  Sonja E Leonhard; David R Cornblath; Hubert P Endtz; James J Sejvar; Bart C Jacobs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-07-30       Impact factor: 10.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.